A carregar...
Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We Come
Lung cancer is the leading cause of cancer mortality. Great advances in non-small cell lung cancer therapy have been seen in the last decade, beginning with the success in treating lung cancer harboring EGFR mutations and ALK-gene rearrangements. The potential of these biomarker-driven therapies has...
Na minha lista:
| Publicado no: | Crit Rev Oncog |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5273860/ https://ncbi.nlm.nih.gov/pubmed/27279233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1615/CritRevOncog.v20.i5-6.70 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|